MetLife, Inc. (NYSE:MET – Get Free Report)’s stock price gapped down before the market opened on Thursday after Barclays lowered their price target on the stock from $91.00 to $90.00. The stock had previously closed at $83.18, but opened at $76.57. Barclays currently has an overweight rating on the stock. MetLife shares last traded at $77.81, with a volume of 541,401 shares trading hands.
Several other equities analysts have also recently issued reports on MET. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. Morgan Stanley cut their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Keefe, Bruyette & Woods lowered their target price on MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a report on Monday, July 8th. TD Cowen started coverage on MetLife in a report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price target on the stock. Finally, Wells Fargo & Company upped their price objective on MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $88.38.
Check Out Our Latest Stock Report on MET
Institutional Inflows and Outflows
MetLife Price Performance
The company’s fifty day simple moving average is $80.59 and its 200-day simple moving average is $74.84. The stock has a market cap of $54.93 billion, a P/E ratio of 15.81, a price-to-earnings-growth ratio of 0.69 and a beta of 1.04. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56.
MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.13 by $0.15. The business had revenue of $17.82 billion during the quarter, compared to analysts’ expectations of $18.57 billion. MetLife had a net margin of 5.27% and a return on equity of 20.41%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter last year, the company posted $1.94 EPS. As a group, sell-side analysts forecast that MetLife, Inc. will post 8.58 EPS for the current year.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.78%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is currently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Trading Halts Explained
- Battle of the Retailers: Who Comes Out on Top?
- How to Plot Fibonacci Price Inflection Levels
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Comparing and Trading High PE Ratio Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.